DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Risperdal (Risperidone) - Neuroleptic Malignant Syndrome - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Neuroleptic Malignant Syndrome ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Risperdal (Risperidone) where reactions include neuroleptic malignant syndrome. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of    Next >>

Possible Risperdal side effects in 31 year old male

Reported by a pharmacist from Japan on 2012-08-27

Patient: 31 year old male, weighing 59.0 kg (129.8 pounds)

Reactions: Eosinophilic Pneumonia, Pulmonary Alveolar Haemorrhage, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Pneumonia Staphylococcal

Adverse event resulted in: death

Drug(s) suspected as cause:
Abilify
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-23
    End date: 2012-06-29

Levotomin
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-01
    End date: 2012-06-29

Methotrimeprazine Maleate

Risperdal
    Dosage: 4mg: 4jun-11jun12(8days) 2mg:12jun-29jun12(18days)
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-04
    End date: 2012-06-29

Rohypnol
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-01
    End date: 2012-06-29

Other drugs received by patient: Diazepam; Promethazine HCL; Miya-BM



Possible Risperdal side effects in 31 year old male

Reported by a physician from Japan on 2012-08-27

Patient: 31 year old male, weighing 59.0 kg (129.8 pounds)

Reactions: Eosinophilic Pneumonia, Pulmonary Alveolar Haemorrhage, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Pneumonia Staphylococcal

Adverse event resulted in: death

Drug(s) suspected as cause:
Abilify
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-23
    End date: 2012-06-29

Levotomin
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-01
    End date: 2012-06-29

Methotrimeprazine Maleate

Risperdal
    Dosage: 4mg: 4jun-11jun12(8days) 2mg:12jun-29jun12(18days)
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-04
    End date: 2012-06-29

Rohypnol
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-01
    End date: 2012-06-29

Other drugs received by patient: Diazepam; Promethazine HCL; Miya-BM



Possible Risperdal side effects in 31 year old male

Reported by a consumer/non-health professional from Japan on 2012-08-16

Patient: 31 year old male, weighing 59.0 kg (129.8 pounds)

Reactions: Eosinophilic Pneumonia, Pulmonary Alveolar Haemorrhage, Acute Respiratory Distress Syndrome, Pneumonia Staphylococcal, Neuroleptic Malignant Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Abilify
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-23
    End date: 2012-06-29

Levotomin
    Administration route: Oral
    Start date: 2012-06-01

Methotrimeprazine Maleate

Risperdal
    Dosage: 4mg: 4jun-11jun12(8days) 2mg:12jun-29jun12(18days)
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-04
    End date: 2012-06-29

Rohypnol
    Start date: 2012-06-01

Other drugs received by patient: Promethazine HCL; Miya-BM; Diazepam



Possible Risperdal side effects in 31 year old male

Reported by a pharmacist from Japan on 2012-08-03

Patient: 31 year old male

Reactions: Eosinophilic Pneumonia, Haemorrhage, Interstitial Lung Disease, Neuroleptic Malignant Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Abilify
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-23
    End date: 2012-07-02

Haloperidol
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-01
    End date: 2012-07-02

Risperdal
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-29
    End date: 2012-07-02

Risperdal
    Administration route: Oral
    Start date: 2012-06-04
    End date: 2012-06-29



Possible Risperdal side effects in 31 year old male

Reported by a consumer/non-health professional from Japan on 2012-08-02

Patient: 31 year old male, weighing 59.0 kg (129.8 pounds)

Reactions: Eosinophilic Pneumonia, Pulmonary Alveolar Haemorrhage, Acute Respiratory Distress Syndrome, Pneumonia Staphylococcal, Neuroleptic Malignant Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Abilify
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-23
    End date: 2012-06-29

Levotomin
    Administration route: Oral
    Start date: 2012-06-01

Risperdal
    Dosage: 4mg: 4jun-11jun12(8days) 2mg:12jun-29jun12(18days)
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-04
    End date: 2012-06-29

Other drugs received by patient: Miya-BM; Promethazine HCL; Rohypnol; Diazepam



Possible Risperdal side effects in

Reported by a pharmacist from Japan on 2012-07-30

Patient:

Reactions: Neuroleptic Malignant Syndrome

Drug(s) suspected as cause:
Keppra
    Administration route: Oral

Risperdal



Possible Risperdal side effects in 57 year old female

Reported by a physician from Peru on 2012-07-23

Patient: 57 year old female

Reactions: Injection Site Abscess, Sensory Disturbance, Neuroleptic Malignant Syndrome, Injection Site Infection

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Risperdal Consta
    Indication: Product Used FOR Unknown Indication



Possible Risperdal side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-29

Patient: female

Reactions: Incorrect Route of Drug Administration, Mutism, Hyperkalaemia, Encephalitis, Hepatic Failure, Multi-Organ Failure, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Gastrointestinal Obstruction, Renal Failure Acute, Hypertriglyceridaemia, Clonus, Cytolytic Hepatitis, Status Epilepticus, Convulsion, Cardiac Failure, Encephalitis Autoimmune, Septic Shock

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Citalopram Hydrobromide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-02-01
    End date: 2010-08-13

Gardasil
    Dosage: injectable suspension. human papilloma virus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)
    Indication: Immunisation
    Start date: 2008-12-01
    End date: 2009-04-01

Risperdal
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-08-01
    End date: 2010-08-13

Tercian
    Dosage: dose : 50 mg/ 5 ml
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-08-01
    End date: 2010-08-13

Other drugs received by patient: Lorazepam



Possible Risperdal side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-26

Patient: female

Reactions: Off Label Use, Encephalitis Autoimmune, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Citalopram Hydrobromide
    Dosage: 10 mg
    Administration route: Oral
    Start date: 2009-02-01
    End date: 2010-08-13

Gardasil
    Indication: Immunisation
    Start date: 2008-12-01
    End date: 2009-04-01

Risperdal
    Start date: 2010-08-01
    End date: 2010-08-13

Tercian
    Start date: 2010-08-01
    End date: 2010-08-13

Other drugs received by patient: Lorazepam



Possible Risperdal side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-25

Patient: female

Reactions: Incorrect Route of Drug Administration, Hyperkalaemia, Mutism, Encephalitis, Hepatic Failure, Multi-Organ Failure, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Renal Failure Acute, Hypertriglyceridaemia, Gastrointestinal Obstruction, Cytolytic Hepatitis, Clonus, Status Epilepticus, Convulsion, Cardiac Failure, Encephalitis Autoimmune, Septic Shock

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Citalopram Hydrobromide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-02-01
    End date: 2010-08-13

Gardasil
    Dosage: injectable suspension. human papilloma virus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)
    Indication: Immunisation
    Start date: 2008-12-01
    End date: 2009-04-01

Risperdal
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-08-01
    End date: 2010-08-13

Tercian
    Dosage: dose : 50 mg/ 5 ml
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-08-01
    End date: 2010-08-13

Other drugs received by patient: Lorazepam



Possible Risperdal side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-20

Patient: female

Reactions: Incorrect Route of Drug Administration, Mutism, Hyperkalaemia, Encephalitis, Hepatic Failure, Multi-Organ Failure, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Gastrointestinal Obstruction, Hypertriglyceridaemia, Renal Failure Acute, Cytolytic Hepatitis, Clonus, Status Epilepticus, Convulsion, Cardiac Failure, Encephalitis Autoimmune, Septic Shock

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Citalopram
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-02-01
    End date: 2010-08-13

Risperdal
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-08-01
    End date: 2010-08-13

Tercian
    Dosage: dose : 50 mg/ 5 ml
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-08-01
    End date: 2010-08-13

Other drugs received by patient: Lorazepam; Gardasil



Possible Risperdal side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-04

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Pneumonia, Staphylococcal Infection, Sepsis, Malnutrition, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Schizophrenia

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2011-06-18



Possible Risperdal side effects in 76 year old female

Reported by a physician from Japan on 2012-05-30

Patient: 76 year old female, weighing 53.0 kg (116.6 pounds)

Reactions: Pulmonary Haemorrhage, Cardio-Respiratory Arrest, Respiratory Failure, Pulmonary Embolism, Neuroleptic Malignant Syndrome, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Risperdal
    Dosage: 3-10 mg/day
    Administration route: Oral
    Start date: 2003-10-16
    End date: 2011-06-20

Risperdal
    Dosage: 3-10 mg/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2003-10-16
    End date: 2011-06-20

Other drugs received by patient: Cibenol; Parlodel; Rohypnol; Lonasen



Possible Risperdal side effects in 49 year old male

Reported by a physician from Japan on 2012-05-24

Patient: 49 year old male

Reactions: Overdose, Neuroleptic Malignant Syndrome, Drug Prescribing Error, Blood Glucose Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-04-22
    End date: 2011-05-05

Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Hirnamine; Phenobarbital TAB; Rhythmy; Bepotastine Besilate; Phenobarbital TAB; Nitrazepam; Hirnamine; Lexotan; Akineton; Clonazepam



Possible Risperdal side effects in male

Reported by a pharmacist from Japan on 2012-04-23

Patient: male

Reactions: Neuroleptic Malignant Syndrome

Drug(s) suspected as cause:
Casodex
    Administration route: Oral

Risperdal

Zoladex



Possible Risperdal side effects in female

Reported by a physician from Germany on 2012-04-16

Patient: female, weighing 110.0 kg (242.0 pounds)

Reactions: Partial Seizures, Tachycardia, Suicide Attempt, Meningitis, Pyrexia, Neuroleptic Malignant Syndrome, Serotonin Syndrome, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
AN Unknown Medication
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

AN Unknown Medication
    Administration route: Oral

Citalopram
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Citalopram
    Administration route: Oral

Lorazepam
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Lorazepam
    Administration route: Oral

Risperdal
    Administration route: Oral

Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Risperdal side effects in 76 year old female

Reported by a physician from Japan on 2012-04-04

Patient: 76 year old female, weighing 53.0 kg (116.6 pounds)

Reactions: Pulmonary Haemorrhage, Respiratory Failure, Pulmonary Embolism, Neuroleptic Malignant Syndrome, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Risperdal

Other drugs received by patient: Cibenol; Lonasen; Parlodel; Rohypnol



Possible Risperdal side effects in female

Reported by a physician from Germany on 2012-04-02

Patient: female, weighing 110.0 kg (242.0 pounds)

Reactions: Partial Seizures, Suicide Attempt, Meningitis, Serotonin Syndrome, Neuroleptic Malignant Syndrome, Pyrexia, Sopor

Drug(s) suspected as cause:
AN Unknown Medication
    Administration route: Oral

AN Unknown Medication
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Citalopram Hydrobromide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Citalopram Hydrobromide
    Administration route: Oral

Lorazepam
    Administration route: Oral

Lorazepam
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Risperdal
    Administration route: Oral



Possible Risperdal side effects in 76 year old female

Reported by a physician from Japan on 2012-03-23

Patient: 76 year old female, weighing 53.0 kg (116.6 pounds)

Reactions: Pulmonary Haemorrhage, Respiratory Failure, Pulmonary Embolism, Neuroleptic Malignant Syndrome, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Risperdal

Other drugs received by patient: Rohypnol; Parlodel; Cibenol; Lonasen



Possible Risperdal side effects in 13 year old female

Reported by a pharmacist from France on 2012-03-08

Patient: 13 year old female

Reactions: Neuroleptic Malignant Syndrome, Liver Disorder

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    End date: 2012-02-18

Risperdal
    Dosage: 0.5-0.5-1mg
    Administration route: Oral
    Indication: Mania
    Start date: 2012-02-14



Possible Risperdal side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-06

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Pneumonia, Staphylococcal Infection, Malnutrition, Sepsis, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Schizophrenia

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2011-06-18



Possible Risperdal side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-03-01

Patient: female

Reactions: Off Label Use, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Citalopram Hydrobromide
    Dosage: 10 mg
    Administration route: Oral
    Start date: 2009-02-01
    End date: 2010-08-13

Risperdal
    Start date: 2010-08-01
    End date: 2010-08-13

Tercian
    Start date: 2010-08-01
    End date: 2010-08-13

Other drugs received by patient: Lorazepam; Gardasil



Possible Risperdal side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-27

Patient: female

Reactions: Atelectasis, Incorrect Route of Drug Administration, Mutism, Hyperkalaemia, Hepatic Failure, Encephalitis, Multi-Organ Failure, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Hypertriglyceridaemia, Gastrointestinal Obstruction, Renal Failure Acute, Autonomic Nervous System Imbalance, Cytolytic Hepatitis, Pseudomonas Infection, Clonus, Status Epilepticus, Haemodialysis, Convulsion, Cardiac Failure, Septic Shock

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Citalopram Hydrobromide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-02-01
    End date: 2010-08-13

Risperdal
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-08-01
    End date: 2010-08-13

Tercian
    Dosage: dose : 50 mg/ 5 ml
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-08-01
    End date: 2010-08-13

Other drugs received by patient: Lorazepam; Gardasil



Possible Risperdal side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-24

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Pneumonia, Staphylococcal Infection, Malnutrition, Sepsis, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Schizophrenia

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2011-06-18



Possible Risperdal side effects in 82 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-11

Patient: 82 year old female

Reactions: Anxiety, Overdose, Renal Failure, Folate Deficiency, Hypoxia, Neuroleptic Malignant Syndrome, Hypocapnia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal

Other drugs received by patient: Oxazepam; Zolpidem; Oxazepam; Valsartan and Hydrochlorothiazide; Lorazepam; Amlodipine Besylate; Lorazepam; Lithium Carbonate; Effexor



Possible Risperdal side effects in 14 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-22

Patient: 14 year old female

Reactions: Myalgia, Hyperthermia, Sepsis, Hypotension, Neuroleptic Malignant Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal



Possible Risperdal side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-12-07

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Pneumonia, Staphylococcal Infection, Malnutrition, Sepsis, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Schizophrenia

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2011-06-18



Possible Risperdal side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-12-02

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Hepatic Function Abnormal, Disseminated Intravascular Coagulation, Sepsis, Neuroleptic Malignant Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lonasen
    Administration route: Oral
    Start date: 2010-02-25
    End date: 2010-06-28

Lonasen
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-01-27
    End date: 2010-02-25

Lonasen
    Administration route: Oral
    Start date: 2009-12-21
    End date: 2010-01-27

Risperdal
    Administration route: Oral
    Start date: 2008-06-12
    End date: 2008-07-11

Risperdal
    Administration route: Oral
    Start date: 2008-11-13
    End date: 2008-12-04

Risperdal
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2008-12-04
    End date: 2009-12-25

Risperdal
    Administration route: Oral
    Start date: 2008-07-25
    End date: 2008-08-08

Risperdal
    Administration route: Oral
    Start date: 2008-07-11
    End date: 2008-07-25

Risperdal
    Administration route: Oral
    Start date: 2008-08-08
    End date: 2008-11-13

Risperdal
    Administration route: Oral
    Start date: 2009-12-28
    End date: 2010-04-28

Risperdal
    Administration route: Oral
    Start date: 2010-04-28
    End date: 2010-06-28

Rohypnol
    Administration route: Oral
    Start date: 2009-08-27
    End date: 2010-04-27

Rohypnol
    Administration route: Oral
    Start date: 2010-05-31
    End date: 2010-06-24

Rohypnol
    Administration route: Oral
    Start date: 2008-06-27
    End date: 2008-07-24

Rohypnol
    Administration route: Oral
    Indication: Insomnia
    Start date: 2009-07-02
    End date: 2009-08-26

Rohypnol
    Administration route: Oral
    Start date: 2008-07-25
    End date: 2008-08-07

Rohypnol
    Administration route: Oral
    Start date: 2008-10-23
    End date: 2009-01-07

Rohypnol
    Administration route: Oral
    Start date: 2008-06-20
    End date: 2008-06-26

Rohypnol
    Administration route: Oral
    Start date: 2009-06-04
    End date: 2009-07-01

Rohypnol
    Administration route: Oral
    Start date: 2009-01-08
    End date: 2009-05-06

Rohypnol
    Administration route: Oral
    Start date: 2008-10-02
    End date: 2008-10-22

Rohypnol
    Administration route: Oral
    Start date: 2010-04-28
    End date: 2010-05-15

Rohypnol
    Administration route: Oral
    Start date: 2010-06-25
    End date: 2010-06-28

Rohypnol
    Administration route: Oral
    Start date: 2008-08-08
    End date: 2008-10-01

Other drugs received by patient: Akineton; Depas; NON-Pyrine Cold Preparation; Abilify; Akineton; Akineton; Akineton; Akineton; Mycosporan; Akineton; Akineton; Akineton; Akineton; Ephedra Teas



Possible Risperdal side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-11-23

Patient: 64 year old male

Reactions: Pneumonia, Staphylococcal Infection, Malnutrition, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Risperdal Consta
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-18



Possible Risperdal side effects in 78 year old female

Reported by a physician from Germany on 2011-11-11

Patient: 78 year old female

Reactions: Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Neuroleptic Malignant Syndrome, Lactic Acidosis

Drug(s) suspected as cause:
Livalo

Metformin HCL
    Dosage: initially 500mg per day
    Administration route: Oral
    Indication: Diabetes Mellitus

Risperdal

Other drugs received by patient: Candesartan Cilexetil; Amaryl



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012